Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jun 28.
Published in final edited form as: Kidney Int. 2016 Mar;89(3):721–723. doi: 10.1016/j.kint.2015.10.019

Adriamycin susceptibility among C57BL/6 substrains

Ehtesham Arif 1, Ashish K Solanki 1, Deepak Nihalani 1
PMCID: PMC5487397  NIHMSID: NIHMS867651  PMID: 26880466

To the Editor

The C57BL/6 mouse inbred strain is the preferred strain for generating various knockout, knock-in, and genetic glomerular disease models. A review of published literature in nephrology journals reveals that C57BL/6 and C57BL/6J have been used interchangeably, largely ignoring the fact that there are significant substrain differences within the C57BL/6 strain.1,2 Thus, it is critical that the nephrology community is well aware of the genetic variations among C57BL/6 substrains3 that result in varying susceptibility toward various injury-inducing agents and may have important implications for results and their interpretation. When the C57BL/6J substrain was shown to resist adriamycin-induced glomerulopathy,4,5 it led to a widespread notion that the C57BL/6 strain is resistant to adriamycin.4 In the present investigation, we demonstrate that unlike C57BL/6J, the C57BL/6N substrain is susceptible to adriamycin-induced glomerulopathy. Adriamycin or saline was retro-orbitally administered in 10-week-old C57BL/6J and C57BL/6N mice. Pre- and post-injection urine samples were collected and analyzed by sodium dodecylsulfate–polyacrylamide gel electrophoresis and enzyme-linked immunosorbent assay for albuminuria estimation. While C57BL/6J mice showed complete absence of albuminuria as reported previously (data not shown),2,4 the C57BL/6N mice displayed significant albuminuria at 4 weeks (Figure 1a and b). Further analysis by scanning and transmission electron microscopy showed significant loss of podocyte morphology and foot process effacement that is consistent with adriamycin-induced glomerulopathy (Figure 1c and d). These results are consistent with recent genetic analysis that suggests these 2 substrains are genetically distinct and vary in their susceptibility to a number of factors.3 We believe that these results should persuade investigators and reviewers to consider the substrain differences when reporting their results and during the review of manuscripts where such a difference could have significant implications.

Figure 1. C57BL/6N mice are susceptible to adriamycin-induced injury.

Figure 1

Adriamycin or saline was retro-orbitally injected in anesthetized C57BL/6N mice (n = 6–8) (15 mg/kg of body weight). Urine from each mouse was collected at 1-week intervals, and the 4-week urine samples were analyzed by sodium dodecylsulfate–polyacrylamide gel electrophoresis followed by Coomassie blue staining and enzyme-linked immunosorbent assay to calculate albumin-creatinine ratios. Albuminuria was noted only in adriamycin-injected mice (a and b; *P < 0.05). Scanning and transmission electron microscopy analysis of kidney tissues from these mice further confirms podocyte damage in adriamycin-injected mice only (c and d). BSA, bovine serum albumin.

References

  • 1.Hakroush S, Cebulla A, Schaldecker T, et al. Extensive podocyte loss triggers a rapid parietal epithelial cell response. J Am Soc Nephrol. 2014;25:927–938. doi: 10.1681/ASN.2013070687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Johnstone DB, Zhang J, George B, et al. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Mol Cell Bi006Fl. 2011;31:2162–2170. doi: 10.1128/MCB.05234-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Simon MM, Greenaway S, White JK, et al. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol. 2013;14:R82. doi: 10.1186/gb-2013-14-7-r82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jeansson M, Bjorck K, Tenstad O, Haraldsson B. Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol. 2009;20:114–122. doi: 10.1681/ASN.2007111205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Simons M, Hartleben B, Huber TB. Podocyte polarity signalling. Curr Opin Nephrol Hypertens. 2009;18:324–330. doi: 10.1097/MNH.0b013e32832e316d. [DOI] [PubMed] [Google Scholar]

RESOURCES